MDA - Market Direction Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : MDA - Market Direction Analysis

SPY 670.92

+0.1%

Nov 7 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Haim R. Branisteanu who wrote (57891)	8/8/2000 6:25:57 PM
From: WhatsUpWithThat	Read Replies (2) of 99985

I'd like to know more about the amortization and the purchased in-process R&D numbers before pasting CSCO, though. These are from acquisitions, but how much did those acquired companies add to the revenue numbers to counter the effect of these huge additions to the expense side? Note that CSCO's gross margin improved over 1999; that ain't all bad. And if you discount the effect of the am and purchased R&D write-off, things look a whole bunch better! Are the two expense numbers mentioned above one-time write-offs? I haven't followed CSCO at all (never owned it), so I don't know the answer, but maybe someone else knows off the top of their head. Cheers WUWT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next